Skip to main content
Fig. 1 | Journal of Nanobiotechnology

Fig. 1

From: Nanoaerosols reduce required effective dose of liposomal levofloxacin against pulmonary murine Francisella tularensis subsp. novicida infection

Fig. 1

Predicted respiratory deposition of various sized particles. This MPPD 3.0 simulation shows deposition fraction of particles in the total (black, solid), nasal (blue, dashed) tracheobronchial (green, dotted), and alveolar (red, alternating) regions based on diameter. The vertical dotted line signifies mean diameter of nanoaerosolized levofloxacin and the vertical dashed line signifies mean diameter of nanoaerosolized liposome-encapsulated levofloxacin

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us